Aelis Farma (XPAR:AELIS) Gross-Profit-to-Asset % : 35.37% (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Aelis Farma Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Aelis Farma's annualized Gross Profit for the quarter that ended in Dec. 2023 was €10.64 Mil. Aelis Farma's average Total Assets over the quarter that ended in Dec. 2023 was €30.09 Mil. Therefore, Aelis Farma's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 35.37%.

Aelis Farma Gross-Profit-to-Asset % Historical Data

The historical data trend for Aelis Farma's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aelis Farma Gross-Profit-to-Asset % Chart

Aelis Farma Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

51.40

11.28

27.65

Aelis Farma Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Gross-Profit-to-Asset %	Get a 7-Day Free Trial					7.75	10.84	8.62	20.43	35.37

Competitive Comparison of Aelis Farma's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Aelis Farma's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aelis Farma's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aelis Farma's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Aelis Farma's Gross-Profit-to-Asset % falls into.

Aelis Farma Gross-Profit-to-Asset % Calculation

Aelis Farma's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2023 )	/	( (Total Assets (A: Dec. 2022 )	+	Total Assets (A: Dec. 2023 ))	/ count )
	=	9.054	/	( (39.218	+	26.281)	/ 2 )
	=	9.054	/	32.7495
	=	27.65 %

Aelis Farma's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	10.64	/	( (33.89	+	26.281)	/ 2 )
	=	10.64	/	30.0855
	=	35.37 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Aelis Farma Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Aelis Farma's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Aelis Farma (XPAR:AELIS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aelis Farma SA (XPAR:AELIS) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

69O:Germany

Address

146, rue Leo Saignat, Bordeaux, FRA, 33077

Website

https://www.aelisfarma.com

Aelis Farma SA is a biotechnology Company specializing in the research and development of treatment's related to brain diseases.

Aelis Farma (XPAR:AELIS) Headlines

No Headlines